|
Video: What is a Stock Split?
|
|
Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology and dermatology, a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical aesthetic devices and, through its majority ownership of Bausch + Lomb Corporation (Bausch + Lomb), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic area of eye health. Co.'s portfolio of products falls into five operating and reportable segments: Salix, International, Solta Medical, Diversified Products and Bausch + Lomb. According to our Bausch Health Companies stock split history records, Bausch Health Companies has had 0 splits. | |
|
Bausch Health Companies (BHC) has 0 splits in our Bausch Health Companies stock split history database.
Looking at the Bausch Health Companies stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bausch Health Companies shares, starting with a $10,000 purchase of BHC, presented on a split-history-adjusted basis factoring in the complete Bausch Health Companies stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$133.73 |
|
End price/share: |
$8.53 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.62% |
|
Average Annual Total Return: |
-24.05% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$638.19 |
|
Years: |
10.00 |
|
|
|
|
|